Cargando…
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era
Background: Cutaneous malignant melanoma is an aggressive neoplasm. In advanced cases, the therapeutic choice depends on the mutational status of BRAF. Fine needle aspiration cytology (FNA) is often applied to the management of patients affected by melanoma, mainly for the diagnosis of metastases. T...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235421/ https://www.ncbi.nlm.nih.gov/pubmed/34207125 http://dx.doi.org/10.3390/diagnostics11061110 |
_version_ | 1783714314018881536 |
---|---|
author | Ronchi, Andrea Montella, Marco Zito Marino, Federica Caraglia, Michele Grimaldi, Anna Argenziano, Giuseppe Moscarella, Elvira Brancaccio, Gabriella Troiani, Teresa Napolitano, Stefania Franco, Renato Cozzolino, Immacolata |
author_facet | Ronchi, Andrea Montella, Marco Zito Marino, Federica Caraglia, Michele Grimaldi, Anna Argenziano, Giuseppe Moscarella, Elvira Brancaccio, Gabriella Troiani, Teresa Napolitano, Stefania Franco, Renato Cozzolino, Immacolata |
author_sort | Ronchi, Andrea |
collection | PubMed |
description | Background: Cutaneous malignant melanoma is an aggressive neoplasm. In advanced cases, the therapeutic choice depends on the mutational status of BRAF. Fine needle aspiration cytology (FNA) is often applied to the management of patients affected by melanoma, mainly for the diagnosis of metastases. The evaluation of BRAF mutational status by sequencing technique on cytological samples may be inconvenient, as it is a time and biomaterial-consuming technique. Recently, BRAF immunocytochemistry (ICC) was applied for the evaluation of BRAF V600E mutational status. Although it may be useful mainly in cytological samples, data about BRAF ICC on cytological samples are missing. Methods: We performed BRAF ICC on a series of 50 FNA samples of metastatic melanoma. BRAF molecular analysis was performed on the same cytological samples or on the corresponding histological samples. Molecular analysis was considered the gold standard. Results: BRAF ICC results were adequate in 49 out of 50 (98%) cases, positive in 15 out of 50 (30%) cases and negative in 34 out of 50 (68%) of cases. Overall, BRAF ICC sensitivity, specificity, positive predictive value and negative predictive value results were 88.2%, 100%, 100% and 94.1%, respectively. The diagnostic performance of BRAF ICC results was perfect when molecular evaluation was performed on the same cytological samples. Hyperpigmentation represents the main limitation of the technique. Conclusions: BRAF ICC is a rapid, cost-effective method for detecting BRAF V600E mutation in melanoma metastases, applicable with high diagnostic performance to cytological samples. It could represent the first step to evaluate BRAF mutational status in cytological samples, mainly in poorly cellular cases. |
format | Online Article Text |
id | pubmed-8235421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82354212021-06-27 Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era Ronchi, Andrea Montella, Marco Zito Marino, Federica Caraglia, Michele Grimaldi, Anna Argenziano, Giuseppe Moscarella, Elvira Brancaccio, Gabriella Troiani, Teresa Napolitano, Stefania Franco, Renato Cozzolino, Immacolata Diagnostics (Basel) Article Background: Cutaneous malignant melanoma is an aggressive neoplasm. In advanced cases, the therapeutic choice depends on the mutational status of BRAF. Fine needle aspiration cytology (FNA) is often applied to the management of patients affected by melanoma, mainly for the diagnosis of metastases. The evaluation of BRAF mutational status by sequencing technique on cytological samples may be inconvenient, as it is a time and biomaterial-consuming technique. Recently, BRAF immunocytochemistry (ICC) was applied for the evaluation of BRAF V600E mutational status. Although it may be useful mainly in cytological samples, data about BRAF ICC on cytological samples are missing. Methods: We performed BRAF ICC on a series of 50 FNA samples of metastatic melanoma. BRAF molecular analysis was performed on the same cytological samples or on the corresponding histological samples. Molecular analysis was considered the gold standard. Results: BRAF ICC results were adequate in 49 out of 50 (98%) cases, positive in 15 out of 50 (30%) cases and negative in 34 out of 50 (68%) of cases. Overall, BRAF ICC sensitivity, specificity, positive predictive value and negative predictive value results were 88.2%, 100%, 100% and 94.1%, respectively. The diagnostic performance of BRAF ICC results was perfect when molecular evaluation was performed on the same cytological samples. Hyperpigmentation represents the main limitation of the technique. Conclusions: BRAF ICC is a rapid, cost-effective method for detecting BRAF V600E mutation in melanoma metastases, applicable with high diagnostic performance to cytological samples. It could represent the first step to evaluate BRAF mutational status in cytological samples, mainly in poorly cellular cases. MDPI 2021-06-18 /pmc/articles/PMC8235421/ /pubmed/34207125 http://dx.doi.org/10.3390/diagnostics11061110 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ronchi, Andrea Montella, Marco Zito Marino, Federica Caraglia, Michele Grimaldi, Anna Argenziano, Giuseppe Moscarella, Elvira Brancaccio, Gabriella Troiani, Teresa Napolitano, Stefania Franco, Renato Cozzolino, Immacolata Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title | Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title_full | Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title_fullStr | Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title_full_unstemmed | Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title_short | Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era |
title_sort | predictive evaluation on cytological sample of metastatic melanoma: the role of braf immunocytochemistry in the molecular era |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235421/ https://www.ncbi.nlm.nih.gov/pubmed/34207125 http://dx.doi.org/10.3390/diagnostics11061110 |
work_keys_str_mv | AT ronchiandrea predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT montellamarco predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT zitomarinofederica predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT caragliamichele predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT grimaldianna predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT argenzianogiuseppe predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT moscarellaelvira predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT brancacciogabriella predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT troianiteresa predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT napolitanostefania predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT francorenato predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera AT cozzolinoimmacolata predictiveevaluationoncytologicalsampleofmetastaticmelanomatheroleofbrafimmunocytochemistryinthemolecularera |